Literature DB >> 30784137

Assessment of atrioventricular conduction by echocardiography and magnetocardiography in normal and anti-Ro/SSA-antibody-positive pregnancies.

B F Cuneo1,2, S Bitant3, J F Strasburger4, A M Kaizer5, R T Wakai3.   

Abstract

OBJECTIVES: The objectives of this study were, first, to evaluate the association between fetal echocardiographic atrioventricular (AV) and magnetocardiographic (fMCG) PR intervals at different gestational ages (GAs) in normal and anti-Ro/SSA-antibody-positive pregnancies; second, to determine if PR interval could be predicted by AV interval; and third, to assess the neonatal outcome of fetuses with prolonged AV and PR intervals, with the goal of developing criteria for fetal first-degree AV block (AVB-I).
METHODS: This was a retrospective study of anti-Ro/SSA-antibody-positive pregnancies (cases) and controls that underwent fMCG and fetal echocardiography at the same recording session. Cardiac cycle length, GA and AV (by mitral inflow/aortic outflow Doppler) and PR (by fMCG) intervals were measured. We tested for significant differences between AV and PR intervals using generalized estimating equations to account for repeat measurements, and assessed whether PR interval could be predicted reliably by AV interval. After delivery, infants with fetal AV or PR interval Z-score ≥ 3 underwent 12-lead electrocardiography.
RESULTS: Thirty-nine controls and 31 cases underwent 46 and 36 simultaneous fMCG and echocardiographic examinations, respectively; 101 controls and nine cases underwent fMCG only. AV and PR intervals increased with GA (P < 0.05 for both). Overall, AV and PR intervals were significantly different from each other (P < 0.001); this difference was not significant when compared between cases and controls (P = 0.222). PR interval could not be predicted accurately from AV interval and GA alone. Three of four cases with AV and PR interval Z-scores > + 3 had postnatal AVB-I despite treatment. The fourth fetus, which had predominately second-degree AVB and rare periods of AVB-I, progressed to third-degree AVB despite treatment with dexamethasone.
CONCLUSIONS: The diagnostic threshold for AVB-I, defined by AV interval Z-score, is GA dependent. Based on the observed data, an AV interval Z-score threshold of 3 (AV interval, 151-167 ms) may be appropriate. Echocardiographic AV interval was not predictive of fMCG-PR interval.
Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  AV block; Sjögren's syndrome; fetal magnetocardiography; fetus

Mesh:

Substances:

Year:  2019        PMID: 30784137      PMCID: PMC6699937          DOI: 10.1002/uog.20245

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  23 in total

1.  Comparison of PR intervals determined by fetal magnetocardiography and pulsed Doppler echocardiography.

Authors:  Yoshiaki Kato; Miho Takahashi-Igari; Takeshi Inaba; Ryo Sumazaki; Hitoshi Horigome
Journal:  Fetal Diagn Ther       Date:  2012-05-22       Impact factor: 2.587

2.  Assessment of left ventricular pre-ejection period in the fetus using simultaneous magnetocardiography and echocardiography.

Authors:  Nana Aba Mensah-Brown; Ronald T Wakai; Bageshree Cheulkar; Shardha Srinivasan; Janette F Strasburger
Journal:  Fetal Diagn Ther       Date:  2010-10-26       Impact factor: 2.587

3.  Simultaneous fetal magnetocardiography and ultrasound/Doppler imaging.

Authors:  Hui Zhao; Mingli Chen; Barry D Van Veen; Janette F Strasburger; Ronald T Wakai
Journal:  IEEE Trans Biomed Eng       Date:  2007-06       Impact factor: 4.538

4.  Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance.

Authors:  G Bergman; H Eliasson; K Bremme; M Wahren-Herlenius; S-E Sonesson
Journal:  Ultrasound Obstet Gynecol       Date:  2009-11       Impact factor: 7.299

Review 5.  Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association.

Authors:  Mary T Donofrio; Anita J Moon-Grady; Lisa K Hornberger; Joshua A Copel; Mark S Sklansky; Alfred Abuhamad; Bettina F Cuneo; James C Huhta; Richard A Jonas; Anita Krishnan; Stephanie Lacey; Wesley Lee; Erik C Michelfelder; Gwen R Rempel; Norman H Silverman; Thomas L Spray; Janette F Strasburger; Wayne Tworetzky; Jack Rychik
Journal:  Circulation       Date:  2014-04-24       Impact factor: 29.690

6.  How to construct 'normal ranges' for fetal variables.

Authors:  P Royston; E M Wright
Journal:  Ultrasound Obstet Gynecol       Date:  1998-01       Impact factor: 7.299

7.  Detection and successful treatment of emergent anti-SSA-mediated fetal atrioventricular block.

Authors:  Bettina F Cuneo; Steven E Ambrose; Wayne Tworetzky
Journal:  Am J Obstet Gynecol       Date:  2016-07-12       Impact factor: 8.661

8.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

9.  Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses.

Authors:  Edgar T Jaeggi; Earl D Silverman; Carl Laskin; John Kingdom; Fraser Golding; Roland Weber
Journal:  J Am Coll Cardiol       Date:  2011-03-29       Impact factor: 24.094

10.  Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.

Authors:  Deborah M Friedman; Mimi Y Kim; Joshua A Copel; Claudine Davis; Colin K L Phoon; Julie S Glickstein; Jill P Buyon
Journal:  Circulation       Date:  2008-01-14       Impact factor: 29.690

View more
  1 in total

Review 1.  Developments in pediatrics in 2020: choices in allergy, autoinflammatory disorders, critical care, endocrinology, genetics, infectious diseases, microbiota, neonatology, neurology, nutrition, ortopedics, respiratory tract illnesses and rheumatology.

Authors:  Carlo Caffarelli; Francesca Santamaria; Michela Procaccianti; Ettore Piro; Valeria Delle Cave; Melissa Borrelli; Angelica Santoro; Federica Grassi; Sergio Bernasconi; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2021-12-07       Impact factor: 2.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.